Cargando…
IL-6–based mortality prediction model for COVID-19: Validation and update in multicenter and second wave cohorts
BACKGROUND: Coronavirus disease 2019 (COVID-19) is a highly variable condition. Validated tools to assist in the early detection of patients at high risk of mortality can help guide medical decisions. OBJECTIVE: We sought to validate externally, as well as in patients from the second pandemic wave i...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Academy of Allergy, Asthma & Immunology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7919507/ https://www.ncbi.nlm.nih.gov/pubmed/33662370 http://dx.doi.org/10.1016/j.jaci.2021.02.021 |
_version_ | 1783658139667660800 |
---|---|
author | Utrero-Rico, Alberto Ruiz-Hornillos, Javier González-Cuadrado, Cecilia Rita, Claudia Geraldine Almoguera, Berta Minguez, Pablo Herrero-González, Antonio Fernández-Ruiz, Mario Carretero, Octavio Taracido-Fernández, Juan Carlos López-Rodriguez, Rosario Corton, Marta Aguado, José María Villar, Luisa María Ayuso-García, Carmen Paz-Artal, Estela Laguna-Goya, Rocio |
author_facet | Utrero-Rico, Alberto Ruiz-Hornillos, Javier González-Cuadrado, Cecilia Rita, Claudia Geraldine Almoguera, Berta Minguez, Pablo Herrero-González, Antonio Fernández-Ruiz, Mario Carretero, Octavio Taracido-Fernández, Juan Carlos López-Rodriguez, Rosario Corton, Marta Aguado, José María Villar, Luisa María Ayuso-García, Carmen Paz-Artal, Estela Laguna-Goya, Rocio |
author_sort | Utrero-Rico, Alberto |
collection | PubMed |
description | BACKGROUND: Coronavirus disease 2019 (COVID-19) is a highly variable condition. Validated tools to assist in the early detection of patients at high risk of mortality can help guide medical decisions. OBJECTIVE: We sought to validate externally, as well as in patients from the second pandemic wave in Europe, our previously developed mortality prediction model for hospitalized COVID-19 patients. METHODS: Three validation cohorts were generated: 2 external with 185 and 730 patients from the first wave and 1 internal with 119 patients from the second wave. The probability of death was calculated for all subjects using our prediction model, which includes peripheral blood oxygen saturation/fraction of inspired oxygen ratio, neutrophil-to-lymphocyte ratio, lactate dehydrogenase, IL-6, and age. Discrimination and calibration were evaluated in the validation cohorts. The prediction model was updated by reestimating individual risk factor effects in the overall cohort (N = 1477). RESULTS: The mortality prediction model showed good performance in the external validation cohorts 1 and 2, and in the second wave validation cohort 3 (area under the receiver-operating characteristic curve, 0.94, 0.86, and 0.86, respectively), with excellent calibration (calibration slope, 0.86, 0.94, and 0.79; intercept, 0.05, 0.03, and 0.10, respectively). The updated model accurately predicted mortality in the overall cohort (area under the receiver-operating characteristic curve, 0.91), which included patients from both the first and second COVID-19 waves. The updated model was also useful to predict fatal outcome in patients without respiratory distress at the time of evaluation. CONCLUSIONS: This is the first COVID-19 mortality prediction model validated in patients from the first and second pandemic waves. The COR+12 online calculator is freely available to facilitate its implementation (https://utrero-rico.shinyapps.io/COR12_Score/). |
format | Online Article Text |
id | pubmed-7919507 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | American Academy of Allergy, Asthma & Immunology |
record_format | MEDLINE/PubMed |
spelling | pubmed-79195072021-03-01 IL-6–based mortality prediction model for COVID-19: Validation and update in multicenter and second wave cohorts Utrero-Rico, Alberto Ruiz-Hornillos, Javier González-Cuadrado, Cecilia Rita, Claudia Geraldine Almoguera, Berta Minguez, Pablo Herrero-González, Antonio Fernández-Ruiz, Mario Carretero, Octavio Taracido-Fernández, Juan Carlos López-Rodriguez, Rosario Corton, Marta Aguado, José María Villar, Luisa María Ayuso-García, Carmen Paz-Artal, Estela Laguna-Goya, Rocio J Allergy Clin Immunol Covid-19 BACKGROUND: Coronavirus disease 2019 (COVID-19) is a highly variable condition. Validated tools to assist in the early detection of patients at high risk of mortality can help guide medical decisions. OBJECTIVE: We sought to validate externally, as well as in patients from the second pandemic wave in Europe, our previously developed mortality prediction model for hospitalized COVID-19 patients. METHODS: Three validation cohorts were generated: 2 external with 185 and 730 patients from the first wave and 1 internal with 119 patients from the second wave. The probability of death was calculated for all subjects using our prediction model, which includes peripheral blood oxygen saturation/fraction of inspired oxygen ratio, neutrophil-to-lymphocyte ratio, lactate dehydrogenase, IL-6, and age. Discrimination and calibration were evaluated in the validation cohorts. The prediction model was updated by reestimating individual risk factor effects in the overall cohort (N = 1477). RESULTS: The mortality prediction model showed good performance in the external validation cohorts 1 and 2, and in the second wave validation cohort 3 (area under the receiver-operating characteristic curve, 0.94, 0.86, and 0.86, respectively), with excellent calibration (calibration slope, 0.86, 0.94, and 0.79; intercept, 0.05, 0.03, and 0.10, respectively). The updated model accurately predicted mortality in the overall cohort (area under the receiver-operating characteristic curve, 0.91), which included patients from both the first and second COVID-19 waves. The updated model was also useful to predict fatal outcome in patients without respiratory distress at the time of evaluation. CONCLUSIONS: This is the first COVID-19 mortality prediction model validated in patients from the first and second pandemic waves. The COR+12 online calculator is freely available to facilitate its implementation (https://utrero-rico.shinyapps.io/COR12_Score/). American Academy of Allergy, Asthma & Immunology 2021-05 2021-03-01 /pmc/articles/PMC7919507/ /pubmed/33662370 http://dx.doi.org/10.1016/j.jaci.2021.02.021 Text en © 2021 American Academy of Allergy, Asthma & Immunology. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Covid-19 Utrero-Rico, Alberto Ruiz-Hornillos, Javier González-Cuadrado, Cecilia Rita, Claudia Geraldine Almoguera, Berta Minguez, Pablo Herrero-González, Antonio Fernández-Ruiz, Mario Carretero, Octavio Taracido-Fernández, Juan Carlos López-Rodriguez, Rosario Corton, Marta Aguado, José María Villar, Luisa María Ayuso-García, Carmen Paz-Artal, Estela Laguna-Goya, Rocio IL-6–based mortality prediction model for COVID-19: Validation and update in multicenter and second wave cohorts |
title | IL-6–based mortality prediction model for COVID-19: Validation and update in multicenter and second wave cohorts |
title_full | IL-6–based mortality prediction model for COVID-19: Validation and update in multicenter and second wave cohorts |
title_fullStr | IL-6–based mortality prediction model for COVID-19: Validation and update in multicenter and second wave cohorts |
title_full_unstemmed | IL-6–based mortality prediction model for COVID-19: Validation and update in multicenter and second wave cohorts |
title_short | IL-6–based mortality prediction model for COVID-19: Validation and update in multicenter and second wave cohorts |
title_sort | il-6–based mortality prediction model for covid-19: validation and update in multicenter and second wave cohorts |
topic | Covid-19 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7919507/ https://www.ncbi.nlm.nih.gov/pubmed/33662370 http://dx.doi.org/10.1016/j.jaci.2021.02.021 |
work_keys_str_mv | AT utreroricoalberto il6basedmortalitypredictionmodelforcovid19validationandupdateinmulticenterandsecondwavecohorts AT ruizhornillosjavier il6basedmortalitypredictionmodelforcovid19validationandupdateinmulticenterandsecondwavecohorts AT gonzalezcuadradocecilia il6basedmortalitypredictionmodelforcovid19validationandupdateinmulticenterandsecondwavecohorts AT ritaclaudiageraldine il6basedmortalitypredictionmodelforcovid19validationandupdateinmulticenterandsecondwavecohorts AT almogueraberta il6basedmortalitypredictionmodelforcovid19validationandupdateinmulticenterandsecondwavecohorts AT minguezpablo il6basedmortalitypredictionmodelforcovid19validationandupdateinmulticenterandsecondwavecohorts AT herrerogonzalezantonio il6basedmortalitypredictionmodelforcovid19validationandupdateinmulticenterandsecondwavecohorts AT fernandezruizmario il6basedmortalitypredictionmodelforcovid19validationandupdateinmulticenterandsecondwavecohorts AT carreterooctavio il6basedmortalitypredictionmodelforcovid19validationandupdateinmulticenterandsecondwavecohorts AT taracidofernandezjuancarlos il6basedmortalitypredictionmodelforcovid19validationandupdateinmulticenterandsecondwavecohorts AT lopezrodriguezrosario il6basedmortalitypredictionmodelforcovid19validationandupdateinmulticenterandsecondwavecohorts AT cortonmarta il6basedmortalitypredictionmodelforcovid19validationandupdateinmulticenterandsecondwavecohorts AT aguadojosemaria il6basedmortalitypredictionmodelforcovid19validationandupdateinmulticenterandsecondwavecohorts AT villarluisamaria il6basedmortalitypredictionmodelforcovid19validationandupdateinmulticenterandsecondwavecohorts AT ayusogarciacarmen il6basedmortalitypredictionmodelforcovid19validationandupdateinmulticenterandsecondwavecohorts AT pazartalestela il6basedmortalitypredictionmodelforcovid19validationandupdateinmulticenterandsecondwavecohorts AT lagunagoyarocio il6basedmortalitypredictionmodelforcovid19validationandupdateinmulticenterandsecondwavecohorts |